Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Encore Medical Corp. (NasdaqNM:ENMC)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
9800 Metric Boulevard
Austin, TX 78758
Phone: (512) 832-9500
Fax: (512) 834-6300
Email: invrel@encoremed.com
Employees (last reported count): 110
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 57%
·Over the last 6 months:
 · 9 insider buys; 1.17M shares (23.5% of insider shares)
·Institutional: 0% (1% of float)
(3 institutions)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Encore Medical Corporation, through its primary operating subsidiary, Encore Orthopedics, Inc. (Encore), designs, manufactures, markets and sells products for the orthopedic implant industry. The Company offers a wide variety of orthopedic reconstructive joint products, trauma products, spinal products and instruments used by surgeons to perform orthopedic surgery. Encore plans to continue to develop or acquire hip, knee and shoulder systems, trauma products, spinal products and line extensions that address the differing preferences of surgeons and new systems for new indications. Encore's products are marketed and sold in the United States, Germany, certain countries in the Middle East and Japan. In the United States, products are sold to hospitals and orthopedic surgeons through a network of independent commissioned sales agents and direct representatives. Outside the United States, Encore's total joint products are sold through distributors.
More from Market Guide: Expanded Business Description

Financial Summary
Encore Medical designs, manufactures, markets and sells products for the orthopedic implant industry primarily in the U.S., Europe and Asia. For the six months ended 6/29/01, sales rose 9% to $17.1 million. Net loss applicable to Common totaled $4.1 million vs. an income of $674 thousand. Revenues reflect the rebuilding of the U.S. sales force. Earnings were offset by several non-recurring charges and the beneficial conversion expense for preferred stock.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Kenneth Davidson, 52
Chairman, Pres, CEO
$50K
August Faske, 47
CFO, Exec. VP
133K
Craig Smith, Ph.D., 57
Exec. VP, Director
174K
Harry Zimmerman, 45
Exec. VP, Gen. Counsel
133K
Jack Cahill, 57
Exec. VP of Sales and Marketing
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:ENMCAs of 31-Aug-2001
Price and Volume
52-Week Low
on 24-Apr-2001
$0.95 
Recent Price$1.64 
52-Week High
on 3-Oct-2000
$2.625
Beta0.57 
Daily Volume (3-month avg)18.3K
Daily Volume (10-day avg)17.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-12.5%
52-Week Change
relative to S&P500
+17.3%
Share-Related Items
Market Capitalization$17.6M
Shares Outstanding10.7M
Float4.60M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$1.70 
Earnings (ttm)-$0.89 
Earnings (mrq)-$0.47 
Sales (ttm)$3.40 
Cash (mrq*)$1.26 
Valuation Ratios
Price/Book (mrq*)0.97 
Price/EarningsN/A 
Price/Sales (ttm)0.48 
Income Statements
Sales (ttm)$31.5M
EBITDA (ttm*)-$2.70M
Income available to common (ttm)-$8.02M
Profitability
Profit Margin (ttm)-13.7%
Operating Margin (ttm)-17.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
29-June-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-10.33%
Return on Equity (ttm)-41.16%
Financial Strength
Current Ratio (mrq*)6.58 
Debt/Equity (mrq*)0.51 
Total Cash (mrq)$13.5M
Short Interest
As of 8-Aug-2001
Shares Short9,000 
Percent of Float0.2%
Shares Short
(Prior Month)
8,000 
Short Ratio0.47 
Daily Volume19.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 29-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.